Date published: 2026-5-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAL Activators

PAL Activators encompass a diverse group of chemical compounds that can enhance the functional activity of the enzyme PAL through various signaling pathways and cellular processes. Forskolin, by activating adenylyl cyclase, increases intracellular cAMP levels, which in turn activates PKA. PKA has the capability to phosphorylate various substrates within the cell, leading to altered protein-protein interactions and enzymatic activities that can enhance the functional activity of PAL. Similarly, IBMX, by preventing the degradation of cAMP, sustains the activation of PKA and thus maintains a biochemical environment conducive to the enhanced activity of PAL.

Other activators function by modulating different elements of cellular signaling pathways. PMA, as an activator of PKC, can lead to the phosphorylation of proteins that directly or indirectly associate with PAL, resulting in an enhancement of PAL's functional activity. Ionomycin, through its role as a calcium ionophore, increases intracellular calcium levels and activates calcium-dependent proteins that can interact with PAL, amplifying PAL's activity. Compounds like okadaic acid and calyculin A inhibit phosphatases, leading to a net increase in the phosphorylation of proteins within PAL's signaling pathways, thereby enhancing PAL's activity. This theme of modulating phosphorylation status is further echoed by EGCG, NaF, and anisomycin, each influencing kinases or phosphatases and thereby impacting the phosphorylation landscape in which PAL operates.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Adenylyl cyclase activator that increases cAMP levels in cells, leading to activation of PKA. PKA can phosphorylate and enhance the activity of PAL-associated proteins, leading to an increased functional activity of PAL.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor that prevents cAMP degradation, resulting in elevated cAMP and subsequent activation of PKA, which can then enhance PAL activity by phosphorylation of associated proteins.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activator of protein kinase C (PKC) which can phosphorylate substrates that interact with PAL, leading to enhanced PAL activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Calcium ionophore that raises intracellular Ca2+ concentration, activating Ca2+-dependent proteins that may interact with PAL, thus enhancing PAL activity.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins within PAL signaling pathways, enhancing PAL activity.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

A potent inhibitor of protein phosphatases 1 and 2A, similar to okadaic acid, which indirectly enhances phosphorylation of proteins associated with PAL, leading to enhanced PAL activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Antioxidant that modulates kinase signaling pathways, potentially altering the phosphorylation status of proteins related to PAL, thus enhancing its activity.

Sodium Fluoride

7681-49-4sc-24988A
sc-24988
sc-24988B
5 g
100 g
500 g
$40.00
$46.00
$100.00
26
(4)

G-protein activator and phosphatase inhibitor that can enhance the phosphorylation status of PAL-related signaling proteins, leading to enhanced PAL activity.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

JNK activator that can enhance the activity of transcription factors that upregulate genes encoding proteins that interact with PAL, leading to enhanced PAL activity.